PIAS1 protects against myocardial ischemia-reperfusion injury by stimulating PPARγ SUMOylation
Abstract Background Myocardial ischemia-reperfusion injury (IRI) has become one of the most serious complications after reperfusion therapy in patients with acute myocardial infarction. Small ubiquitin-like modification (SUMOylation) is a reversible process, including SUMO E1-, E2-, and E3-mediated...
| Autori principali: | , , , , , |
|---|---|
| Natura: | Articolo |
| Lingua: | English |
| Pubblicazione: |
BMC
2018-11-01
|
| Serie: | BMC Cell Biology |
| Soggetti: | |
| Accesso online: | http://link.springer.com/article/10.1186/s12860-018-0176-x |